Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia

[1]  W. Zhou,et al.  Global Protein Differential Expression Profiling of Cerebrospinal Fluid Samples Pooled from Chinese Sporadic CJD and non-CJD Patients , 2014, Molecular Neurobiology.

[2]  R. Kaji,et al.  Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia , 2013, Journal of Neuroinflammation.

[3]  T. Yuasa,et al.  Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt–Jakob disease patients , 2012, Journal of Neuroimmunology.

[4]  M. Crescenzi,et al.  Increased levels of acute-phase inflammatory proteins in plasma of patients with sporadic CJD , 2012, Neurology.

[5]  B. Chesebro,et al.  Early Cytokine Elevation, PrPres Deposition, and Gliosis in Mouse Scrapie: No Effect on Disease by Deletion of Cytokine Genes IL-12p40 and IL-12p35 , 2012, Journal of Virology.

[6]  A. Bizzi,et al.  Sporadic human prion diseases: molecular insights and diagnosis , 2012, The Lancet Neurology.

[7]  Guang-Xian Zhang,et al.  CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  T. Yuasa,et al.  Detection of anti-glutamate receptor ε2 and anti-N-methyl-d-aspartate receptor antibodies in a patient with sporadic Creutzfeldt–Jakob disease , 2012, Journal of Neurology.

[9]  C. Moussa,et al.  Inflammation in the early stages of neurodegenerative pathology , 2011, Journal of Neuroimmunology.

[10]  Y. Shiga,et al.  Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt–Jakob disease , 2010, Laboratory Investigation.

[11]  R. Ransohoff,et al.  Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. , 2010, Immunity.

[12]  B. Chesebro,et al.  Analysis of Protein Levels of 24 Cytokines in Scrapie Agent-Infected Brain and Glial Cell Cultures from Mice Differing in Prion Protein Expression Levels , 2009, Journal of Virology.

[13]  J. Collinge,et al.  A role of cellular prion protein in programming T‐cell cytokine responses in disease , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[15]  F. Jirik,et al.  Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis. , 2008, The American journal of pathology.

[16]  Richard C. Moore,et al.  Genes contributing to prion pathogenesis. , 2008, The Journal of general virology.

[17]  A. Nitta,et al.  Production and functions of IL-17 in microglia , 2008, Journal of Neuroimmunology.

[18]  Jia Newcombe,et al.  Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. , 2008, The American journal of pathology.

[19]  S. Nakae,et al.  IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[20]  I. Zerr,et al.  Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt–Jakob disease , 2006, Journal of Neuroimmunology.

[21]  K. Eguchi,et al.  14-3-3 Protein, Total Tau and Phosphorylated Tau in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease and Neurodegenerative Disease in Japan , 2006, Cellular and Molecular Neurobiology.

[22]  N. Rothwell,et al.  The role of inflammation in CNS injury and disease , 2006, British journal of pharmacology.

[23]  U. Heinemann,et al.  Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. , 2005, Archives of neurology.

[24]  G. Sobue,et al.  Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease , 2005, Acta Neuropathologica.

[25]  F. Mihara,et al.  Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. , 2005, Brain : a journal of neurology.

[26]  Angus Lauder,et al.  Accelerated Prion Disease in the Absence of Interleukin-10 , 2004, Journal of Virology.

[27]  M. Burwinkel,et al.  Role of cytokines and chemokines in prion infections of the central nervous system , 2004, International Journal of Developmental Neuroscience.

[28]  P. Cras,et al.  The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease , 2002, Neurobiology of Aging.

[29]  M. Pasparakis,et al.  Tumor Necrosis Factor Alpha-Deficient, but Not Interleukin-6-Deficient, Mice Resist Peripheral Infection with Scrapie , 2000, Journal of Virology.

[30]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[31]  A. Green,et al.  Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt–Jakob disease , 1999, Neurology.

[32]  T. Sato,et al.  Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. , 1999, Archives of neurology.

[33]  K. Doh-ura,et al.  Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. , 1993, Biochemical and biophysical research communications.

[34]  R. Shin,et al.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. , 1992, The American journal of pathology.